Dimethylacetamide in Rooster Semen Cryopreservation

Cryo Letters. 2021 Jan-Feb;42(1):39-43.

Abstract

Background: Sperm cryopreservation of cockerels is a major challenge, and so far there is no adequate information to enable commercial use of frozen semen.

Objective: To test the toxicity of dimethylacetamide (DMA).

Materials and methods: DMA was added at 3%, 6%, 9% and 12% to the freezing diluent, and maintained for equilibration with the semen sample for 1 min, 3 min, 5 min, 7 min and 9 min prior to freezing. Thawed semen was evaluated for kinetic characteristics by computer-assisted semen analysis (CASA) and for structural and functional properties by flow cytometry (plasma membrane rupture, mitochondrial functionality and plasma membrane functionality).

Results and conclusion: The addition of 6% DMA for 3-min equilibration resulted in the highest total and progressive motility, 42.0% and 36.9%, respectively. The point of intersection between a good protection and low plasma membrane rupture was obtained with the addition of 6% of DMA for 3-min equilibration with the rooster semen.

MeSH terms

  • Acetamides / pharmacology*
  • Animals
  • Chickens*
  • Cryopreservation / veterinary*
  • Cryoprotective Agents / pharmacology
  • Freezing
  • Male
  • Semen
  • Semen Analysis
  • Semen Preservation / veterinary*
  • Sperm Motility
  • Spermatozoa

Substances

  • Acetamides
  • Cryoprotective Agents
  • dimethylacetamide